News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article details the top five stock downgrades by Wall Street analysts on Thursday. Notably, a Raymond James analyst downgraded Humana (NYSE: HUM) from Outperform to Market Perform. Other companies experiencing downgrades include Paymentus Holdings Inc (NYSE: PAY), Masco Corp (NYSE: MAS), Fiverr International …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana announced plans to exit some of its less profitable Medicare Advantage markets in 2027, which is expected to affect approximately 600,000 members. The company's primary goal is to achieve a sustainable margin of at least 3%. Despite these exits, Humana reported significant individual …
Humana is adjusting its Medicare Advantage plans for 2027, discontinuing some in certain markets due to rising medical costs and changes in federal reimbursement. While not all enrollees will be affected, members are advised to review their Annual Notice of Change (ANOC) and consider …
Ihuman Inc (IH) has a robust financial status despite its low operating efficiency, with a current financial score of 6.75, ranking 300 out of 485 in the Software & IT Services industry. The company's latest quarterly revenue decreased by 8.51% year-over-year to $26.86M, and …
Humacyte Inc (HUMA) has an institutional shareholding score of 3.00, placing it 191st out of 384 in the Biotechnology & Medical Research industry. Institutional investors currently hold 32.47% of shares, a 29.83% increase quarter-over-quarter. While some institutions like Fresenius SE & Co KGaA hold …
Humana's Q2 earnings call highlighted that the company is on track for its 2026 performance goals, emphasizing planned Medicare Advantage margin expansion by 2027 and aiming for a 3% pretax margin by 2028. The company is strategically exiting certain plans and focusing on efficiency …
Halper Sadeh LLC is investigating whether certain officers and directors of Humana Inc. breached their fiduciary duties to shareholders. The firm is encouraging long-term Humana shareholders to contact them to discuss their legal rights and options, which could include corporate governance reforms or financial …
Sharemaestro market context Trend signal active 52 weeks +25.6%The Ensign Group, Humana, Vitas Healthcare, and Option Care Health recently reported their second-quarter earnings. Ensign Group saw strong demand and anticipates a busy acquisition period, planning to expand into new states and having acquired 71 assets since 2025. Humana reaffirmed its commitment to …
Humana Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …
Humana Inc. reported Q2 2026 earnings, reiterating its goal of achieving a sustainable 3% pre-tax margin by 2028 through improved Medicare Advantage plan quality and operational efficiency. Despite strong revenue growth, profit margins have seen a significant decline, with Q2 2026 pre-tax margin at …
This article first appeared on GuruFocus. Operating Cost Ratio: Down 120 basis points year over year in Q2. Full-Year Operating Cost Reduction Expectation: Approximately 150 basis points. 2026 Cost Trend: High single-digit range, 7% to 8%, inclusive of medical and pharmacy. Individual MA Pretax …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana Inc. reported strong second-quarter 2026 results, with revenue reaching $40.9 billion and diluted EPS of $5.73. This represents double-digit year-over-year growth in both revenue (26.2%) and net income (27.6%), driven primarily by expansion in Medicare membership and higher per-member premiums. The company also …
Humana Inc. (HUM) filed its unaudited quarterly report Form 10-Q for the period ended June 30, 2026. The report details $1.32 billion of commercial paper outstanding, $5.0 billion in revolving borrowing capacity, and the completed acquisition of MaxHealth for approximately $908 million. The company …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana reports a higher medical cost ratio and reaffirms, rather than raises, its full-year earnings guidance. Continue Reading
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana (HUM) reported $40.89 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 26.2%. EPS of $7.61 for the same period compares to $6.27 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $40.65 billion, …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Humana stock has delivered a powerful run over the past year, yet on the current checks it no longer looks obviously cheap or obviously expensive. …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana, a top-tier medical insurer specializing in Medicare Advantage plans, is expected to have a weak 2026 despite making solid progress early in the year. The company's focus on serving the elderly aligns with US demographic trends and the increasing penetration of Medicare Advantage …
Financial report ©Adobe Stock Images Humana Inc. (NYSE:HUM) shares fell nearly 9% in pre-market trading on Wednesday despite the health insurer reporting second-quarter earnings and revenue that exceeded Wall Street expectations while reaffirming its full-year adjusted earnings guidance. The company posted adjusted earnings of …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humacyte, Inc. (HUMA) stock recently closed down 6.44% at $0.63, underperforming the S&P 500. The company's stock has also fallen by 15.62% over the past month, trailing its sector. Investors are looking forward to its upcoming earnings report, with projections of a 58.33% increase …
Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts' consensus estimates. Is now the time …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana (HUM) came out with quarterly earnings of $7.61 per share, beating the Zacks Consensus Estimate of $6.22 per share. This compares to earnings of $6.27 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana cut its full-year earnings outlook on Wednesday as lower Medicare Advantage Star Ratings reduced the quality bonuses it receives from the federal government. The health insurer revised its full-year GAAP earnings target to a minimum of $6.52 per share, compared with its earlier …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana Inc. (NYSE: HUM) has announced the election of Paul Smith and Frederick Crawford to its Board of Directors, effective immediately. Smith, Chief Commercial Officer at Anthropic, PBC, brings over 30 years of experience in enterprise technology go-to-market strategies, while Crawford, former President and …
Investing.com -- Humana Inc. (NYSE: HUM) reported second-quarter earnings before the open on Wednesday, topping consensus expectations. Adjusted earnings per share of $7.61 beat the analyst estimate of $7.23 by $0.38, though shares fell 8.7% premarket following the results. Revenue for the quarter reached …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana, Inc. reported higher second-quarter profit with strong revenue growth but trimmed its fiscal 2026 reported earnings outlook. Despite the cut in the reported EPS view, the company maintained its adjusted earnings and revenue outlook for the fiscal year. Following the announcement, Humana's shares …
Redwood Grove Capital LLC increased its stake in Humana Inc. by 8.7% in the first quarter, making it their 4th largest holding. Other hedge funds also adjusted their positions in the health insurance provider. Humana recently reported strong quarterly earnings, beating analyst expectations, and …
Humana Inc. reported its second-quarter revenue reached $40.87 billion, surpassing FactSet's estimate of $40.57 billion. The company also announced that its Q2 adjusted earnings and revenue rose, and it affirmed its full-year 2026 adjusted EPS outlook of at least $9.00, exceeding FactSet's estimate of …
July 29 (Reuters) - Humana on Wednesday beat Wall Street estimates for second-quarter earnings as the health insurer's spend on medical services was in line with expectations, but it left its annual adjusted profit forecast unchanged. Shares of the company were down about 9% …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis, $17.91 on an Adjusted basis 2Q26 Insurance segment GAAP benefit ratio of 91.2 percent, in …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Arrowstreet Capital Limited Partnership increased its stake in Humana Inc. by 26.7% in the first quarter, now owning 235,493 shares valued at $40.83 million. Other hedge funds also adjusted their positions, and institutional investors collectively own 92.38% of the company's stock. Analysts have given …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Humana (HUM) is back in focus after new research from Humana Healthcare Research on Medicare Advantage selection coincided with rising attention on the company's upcoming …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Weekly market data show a softer latest week, lighter turnover and mixed confirmation after a sharp medium-term advance.
Search by ticker symbol or company name and select a result to open its chart.